DK1220863T3 - Purinderivater - Google Patents

Purinderivater

Info

Publication number: DK1220863T3
Authority: DK; Denmark
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-10-14

Application number

DK00964566T

Other languages

English (en)

Inventor

Sandra Marina Monaghan

Original Assignee

Pfizer Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2000-10-06

Publication date

2003-08-11

2000-10-06 Application filed by Pfizer Ltd filed Critical Pfizer Ltd

2003-08-11 Application granted granted Critical

2003-08-11 Publication of DK1220863T3 publication Critical patent/DK1220863T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)

DK00964566T 1999-10-14 2000-10-06 Purinderivater DK1220863T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9924363.6A GB9924363D0 (en)	1999-10-14	1999-10-14	Purine derivatives
PCT/IB2000/001444 WO2001027130A1 (en)	1999-10-14	2000-10-06	Purine derivatives

Publications (1)

Publication Number	Publication Date
DK1220863T3 true DK1220863T3 (da)	2003-08-11

Family

ID=10862760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00964566T DK1220863T3 (da)	1999-10-14	2000-10-06	Purinderivater

Country Status (50)

Country	Link
US (1)	US6350735B1 (da)
EP (1)	EP1220863B1 (da)
JP (1)	JP3994007B2 (da)
KR (1)	KR20020037774A (da)
CN (1)	CN1151167C (da)
AP (1)	AP1442A (da)
AR (1)	AR023275A1 (da)
AT (1)	ATE238336T1 (da)
AU (1)	AU768308B2 (da)
BG (1)	BG106569A (da)
BR (1)	BR0011776A (da)
CA (1)	CA2387531C (da)
CO (1)	CO5251399A1 (da)
CR (1)	CR6584A (da)
CZ (1)	CZ20021223A3 (da)
DE (1)	DE60002356T2 (da)
DK (1)	DK1220863T3 (da)
DZ (1)	DZ3159A1 (da)
EA (1)	EA004655B1 (da)
EC (1)	ECSP003712A (da)
EE (1)	EE200200193A (da)
ES (1)	ES2193990T3 (da)
GB (1)	GB9924363D0 (da)
GE (1)	GEP20043269B (da)
GT (1)	GT200000172A (da)
HK (1)	HK1047110B (da)
HN (1)	HN2000000204A (da)
HU (1)	HUP0203483A2 (da)
IL (1)	IL146342A0 (da)
IS (1)	IS6165A (da)
MA (1)	MA26828A1 (da)
MX (1)	MXPA02003812A (da)
MY (1)	MY136242A (da)
NO (1)	NO20021692L (da)
NZ (1)	NZ515323A (da)
OA (1)	OA12059A (da)
PA (1)	PA8503501A1 (da)
PE (1)	PE20010755A1 (da)
PL (1)	PL354932A1 (da)
PT (1)	PT1220863E (da)
SI (1)	SI1220863T1 (da)
SK (1)	SK4842002A3 (da)
SV (1)	SV2002000198A (da)
TN (1)	TNSN00202A1 (da)
TR (1)	TR200200985T2 (da)
UA (1)	UA66945C2 (da)
UY (1)	UY26397A1 (da)
WO (1)	WO2001027130A1 (da)
YU (1)	YU88901A (da)
ZA (1)	ZA200202849B (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
OA12609A (en) *	2001-05-25	2006-06-09	Pfizer	An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases.
AU2002362443B2 (en) *	2001-10-01	2008-05-15	University Of Virginia Patent Foundation	2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
US20090170803A1 (en) *	2002-04-10	2009-07-02	Linden Joel M	Adjunctive treatment of biological diseases
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
US20050033044A1 (en)	2003-05-19	2005-02-10	Bristol-Myers Squibb Pharma Company	Methods for preparing 2-alkynyladenosine derivatives
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
AU2005267706B2 (en) *	2004-08-02	2011-12-08	University Of Virginia Patent Foundation	2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
US7576069B2 (en) *	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7442687B2 (en) *	2004-08-02	2008-10-28	The University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
CA2611216A1 (en) *	2005-06-15	2006-12-21	Pfizer Limited	3-phenylazetidine derivatives as dopamine agonists
CN100352823C (zh) *	2005-08-19	2007-12-05	浙江车头制药有限公司	一种腺嘌呤衍生物的制备方法
PL2532679T3 (pl)	2005-10-21	2017-09-29	Novartis Ag	Ludzkie przeciwciała przeciwko IL13 i zastosowania terapeutyczne
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
US20080027022A1 (en) *	2006-02-08	2008-01-31	Linden Joel M	Method to treat gastric lesions
US8178509B2 (en)	2006-02-10	2012-05-15	University Of Virginia Patent Foundation	Method to treat sickle cell disease
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
CN101516885A (zh)	2006-09-29	2009-08-26	诺瓦提斯公司	作为pi3k脂质激酶抑制剂的吡唑并嘧啶类化合物
WO2008052734A1 (en)	2006-10-30	2008-05-08	Novartis Ag	Heterocyclic compounds as antiinflammatory agents
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
EP2231642B1 (en)	2008-01-11	2013-10-23	Novartis AG	Pyrimidines as kinase inhibitors
JP2012516345A (ja)	2009-01-29	2012-07-19	ノバルティスアーゲー	星細胞腫治療用置換ベンゾイミダゾール
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
CA2770873A1 (en)	2009-08-12	2011-02-17	Novartis Ag	Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
SG10201404886PA (en)	2009-08-17	2014-10-30	Intellikine Llc	Heterocyclic compounds and uses thereof
BR112012008061A2 (pt)	2009-08-20	2016-03-01	Novartis Ag	compostos de oxima heterocíclica
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
EP2673277A1 (en)	2011-02-10	2013-12-18	Novartis AG	[1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
PH12013501758A1 (en)	2011-02-25	2013-10-14	Irm Llc	Pyrazolo [1,5-a] pyridines as trk inhibitors
CA2848809A1 (en)	2011-09-15	2013-03-21	Novartis Ag	6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase
US9174994B2 (en)	2011-11-23	2015-11-03	Intellikine, Llc	Enhanced treatment regimens using mTor inhibitors
AU2013243097A1 (en)	2012-04-03	2014-10-09	Novartis Ag	Combination products with tyrosine kinase inhibitors and their use
EP2968340A4 (en)	2013-03-15	2016-08-10	Intellikine Llc	COMBINING KINASE INHIBITORS AND USES THEREOF
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
AU2015294889B2 (en)	2014-07-31	2018-03-15	Novartis Ag	Combination therapy
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en) *	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
WO1988003147A1 (en) *	1986-10-31	1988-05-05	Warner-Lambert Company	Selected n6-substituted adenosines having selective a2 binding activity
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5877180A (en) *	1994-07-11	1999-03-02	University Of Virginia Patent Foundation	Method for treating inflammatory diseases with A2a adenosine receptor agonists
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
CA2347512C (en) *	1998-10-16	2005-12-06	Pfizer Inc.	Adenine derivatives

1999
- 1999-10-14 GB GBGB9924363.6A patent/GB9924363D0/en not_active Ceased
2000
- 2000-09-14 HN HN2000000204A patent/HN2000000204A/es unknown
- 2000-09-26 PA PA20008503501A patent/PA8503501A1/es unknown
- 2000-10-06 KR KR1020027004748A patent/KR20020037774A/ko active IP Right Grant
- 2000-10-06 DE DE60002356T patent/DE60002356T2/de not_active Expired - Fee Related
- 2000-10-06 TR TR2002/00985T patent/TR200200985T2/xx unknown
- 2000-10-06 SI SI200030102T patent/SI1220863T1/xx unknown
- 2000-10-06 GE GEAP20006243A patent/GEP20043269B/en unknown
- 2000-10-06 UA UA2002042943A patent/UA66945C2/uk unknown
- 2000-10-06 CZ CZ20021223A patent/CZ20021223A3/cs unknown
- 2000-10-06 PL PL00354932A patent/PL354932A1/xx not_active Application Discontinuation
- 2000-10-06 YU YU88901A patent/YU88901A/sh unknown
- 2000-10-06 SK SK484-2002A patent/SK4842002A3/sk unknown
- 2000-10-06 DK DK00964566T patent/DK1220863T3/da active
- 2000-10-06 BR BR0011776-5A patent/BR0011776A/pt not_active IP Right Cessation
- 2000-10-06 HU HU0203483A patent/HUP0203483A2/hu unknown
- 2000-10-06 PT PT00964566T patent/PT1220863E/pt unknown
- 2000-10-06 DZ DZ003159A patent/DZ3159A1/xx active
- 2000-10-06 EE EEP200200193A patent/EE200200193A/xx unknown
- 2000-10-06 CA CA002387531A patent/CA2387531C/en not_active Expired - Fee Related
- 2000-10-06 AT AT00964566T patent/ATE238336T1/de not_active IP Right Cessation
- 2000-10-06 NZ NZ515323A patent/NZ515323A/en unknown
- 2000-10-06 IL IL14634200A patent/IL146342A0/xx unknown
- 2000-10-06 AP APAP/P/2002/002478A patent/AP1442A/en active
- 2000-10-06 WO PCT/IB2000/001444 patent/WO2001027130A1/en active IP Right Grant
- 2000-10-06 CN CNB008096287A patent/CN1151167C/zh not_active Expired - Fee Related
- 2000-10-06 OA OA1200200102A patent/OA12059A/en unknown
- 2000-10-06 MX MXPA02003812A patent/MXPA02003812A/es active IP Right Grant
- 2000-10-06 EA EA200101107A patent/EA004655B1/ru not_active IP Right Cessation
- 2000-10-06 ES ES00964566T patent/ES2193990T3/es not_active Expired - Lifetime
- 2000-10-06 EP EP00964566A patent/EP1220863B1/en not_active Expired - Lifetime
- 2000-10-06 AU AU75488/00A patent/AU768308B2/en not_active Ceased
- 2000-10-06 JP JP2001530348A patent/JP3994007B2/ja not_active Expired - Fee Related
- 2000-10-12 CO CO00077985A patent/CO5251399A1/es not_active Application Discontinuation
- 2000-10-12 MY MYPI20004790A patent/MY136242A/en unknown
- 2000-10-12 EC EC2000003712A patent/ECSP003712A/es unknown
- 2000-10-12 GT GT200000172A patent/GT200000172A/es unknown
- 2000-10-13 UY UY26397A patent/UY26397A1/es not_active Application Discontinuation
- 2000-10-13 TN TNTNSN00202A patent/TNSN00202A1/fr unknown
- 2000-10-13 SV SV2000000198A patent/SV2002000198A/es unknown
- 2000-10-13 PE PE2000001098A patent/PE20010755A1/es not_active Application Discontinuation
- 2000-10-13 AR ARP000105421A patent/AR023275A1/es unknown
- 2000-10-16 US US09/688,624 patent/US6350735B1/en not_active Expired - Fee Related
2001
- 2001-11-16 IS IS6165A patent/IS6165A/is unknown
2002
- 2002-02-08 CR CR6584A patent/CR6584A/es not_active Application Discontinuation
- 2002-04-02 BG BG106569A patent/BG106569A/xx unknown
- 2002-04-09 MA MA26590A patent/MA26828A1/fr unknown
- 2002-04-10 NO NO20021692A patent/NO20021692L/no not_active Application Discontinuation
- 2002-04-11 ZA ZA200202849A patent/ZA200202849B/xx unknown
- 2002-11-29 HK HK02108605.8A patent/HK1047110B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
ECSP003712A (es)	2002-05-23
BR0011776A (pt)	2002-03-12
IS6165A (is)	2001-11-16
HK1047110B (zh)	2005-03-04
CR6584A (es)	2004-01-14
GEP20043269B (en)	2004-06-25
ATE238336T1 (de)	2003-05-15
TR200200985T2 (tr)	2002-10-21
NZ515323A (en)	2003-10-31
OA12059A (en)	2006-05-03
EA004655B1 (ru)	2004-06-24
YU88901A (sh)	2004-09-03
UA66945C2 (uk)	2004-06-15
TNSN00202A1 (fr)	2005-11-10
ZA200202849B (en)	2003-06-25
CN1151167C (zh)	2004-05-26
MXPA02003812A (es)	2002-09-30
KR20020037774A (ko)	2002-05-22
DZ3159A1 (fr)	2001-04-19
CO5251399A1 (es)	2003-02-28
EP1220863B1 (en)	2003-04-23
AU7548800A (en)	2001-04-23
CZ20021223A3 (cs)	2003-05-14
NO20021692D0 (no)	2002-04-10
MA26828A1 (fr)	2004-12-20
AP2002002478A0 (en)	2002-06-30
PA8503501A1 (es)	2002-02-21
ES2193990T3 (es)	2003-11-16
CA2387531C (en)	2006-12-05
HUP0203483A2 (hu)	2003-02-28
GB9924363D0 (en)	1999-12-15
EE200200193A (et)	2003-06-16
PT1220863E (pt)	2003-07-31
WO2001027130A1 (en)	2001-04-19
HN2000000204A (es)	2001-06-21
JP3994007B2 (ja)	2007-10-17
AP1442A (en)	2005-06-29
SV2002000198A (es)	2002-02-05
EP1220863A1 (en)	2002-07-10
JP2003511459A (ja)	2003-03-25
CA2387531A1 (en)	2001-04-19
EA200101107A1 (ru)	2002-10-31
UY26397A1 (es)	2001-05-31
BG106569A (en)	2002-12-29
SK4842002A3 (en)	2003-06-03
DE60002356D1 (de)	2003-05-28
US6350735B1 (en)	2002-02-26
MY136242A (en)	2008-08-29
CN1358192A (zh)	2002-07-10
GT200000172A (es)	2002-04-05
DE60002356T2 (de)	2004-02-19
PL354932A1 (en)	2004-03-22
SI1220863T1 (en)	2003-10-31
NO20021692L (no)	2002-04-10
HK1047110A1 (en)	2003-02-07
AU768308B2 (en)	2003-12-04
AR023275A1 (es)	2002-09-04
PE20010755A1 (es)	2001-07-17
IL146342A0 (en)	2002-07-25

Publication	Publication Date	Title
ATE321065T1 (de)	2006-04-15	Purin-derivate
DE60002356D1 (de)	2003-05-28	Purin-derivate
IS6196A (is)	2001-12-11	Púrín afleiður
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
DE60119492D1 (de)	2006-06-14	Purinderivate
ATE267836T1 (de)	2004-06-15	Purinderivate
DE60009747D1 (de)	2004-05-13	Admantan-derivate
DE50010060D1 (de)	2005-05-19	Thiazolylamid-derivate
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE273272T1 (de)	2004-08-15	Mevinolinderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
DE60006703D1 (de)	2003-12-24	4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DE60025348D1 (de)	2006-03-30	Ethansulfonyl-piperidin-derivate
DK1178984T3 (da)	2003-06-10	1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
ATE269328T1 (de)	2004-07-15	1-cycloalkylpyrazolyl-benzoyl-derivate
DK1090019T3 (da)	2005-02-07	Adenosinderivater